A new study published in the Journal of Cancer found that just one dose of psilocybin can significantly reduce depression and anxiety in cancer patients. The research suggests that this psychedelic substance may be a game-changer for treating depression in these patients, with benefits seen for up to two years after treatment. The study’s lead author notes that further randomized testing is needed to confirm the findings, but if successful, it could pave the way for greater use of psilocybin as an antidepressant alternative.
Source: https://people.com/recreational-drug-helps-cancer-patients-with-depression-anxiety-not-weed-11756160